BB&T upgraded to Outperform from Neutral at Credit Suisse Credit Suisse upgraded BB&T to Outperform citing valuation and high growth at the company's lite insurance subsidiary. The firm raised its price target for shares to $46.50 from $43.
BB&T remains an underappreciated story, says BofA/Merrill BofA/Merrill reiterated its Buy rating and $44 price target on BB&T and said it remains an underappreciated and under-owned. The firm notes BB&T is using excess capital and currency strength to return capital to shareholders and pursue accretive deals. BofA/Merrill thinks the Susquehanna deal could prove more beneficial than the market perceives and its excess liquidity position makes it more rate sensitive versus peers. Shares are Buy rated with a $44 price target.